Factory Retatrutide API 99% Purity CAS 2381089-83-2

Ritatrutide CAS No. 2381089-83-2

1.High quality with competitive price

2.GMP-compliant ​ production with ​MAH B License​ (Drug Production License, China)
3. High Batch-to-Batch Consistency: ≥ 99% purity, compliant with USP/EP standards.

4.DMF ready sample

5.High-purity ​ peptides with strict ​ impurity control ​ (HPLC, MS verified)

We are an approved supplier of ​ Tirzepatide APIs ​ to US 503A compounding pharmacies under the ​ National Drug Code (NDC)​ . Our facility and products have undergone ​ rigorous on-site audits and testing ​ by NDC clients, receiving ​ high praise for quality and compliance .

Samples  : Samples are available. Samples are for free and you just need to bear the fright.

Payment : TT/Payoneer/Paypal

Lead Time: Segaglutide/Tirzepatide/Retatrutide APIs are in stock.

We are a  specialized  peptide API manufacturer integrating R&D and production, co-founded by seasoned peptide drug experts and overseas pharmaceutical talents. As a high-tech enterprise certified by the Chinese government, we specialize in innovative therapies for metabolic diseases (e.g., diabetes, obesity, NAFLD) and leverage our proprietary long-chain peptide synthesis platform to enable large-scale, eco-friendly production​while enhancing drug accessibility.

The offices and labs of Shenzhen Alvantis pharma co., Ltd. are located in Nanshan District, Shenzhen city, China, the factory is located in Zhongshan City, a neighboring city. Our core R&D team all have 15 years of experience in peptide drug development, covering 80% of the peptide drugs that have been marketed. The annual peptide production capacity of the factory reaches 200 kg. We have exported dozens of kilograms of NDC goods to the United States and have submitted review documents to the FDA.

Factory in Zhongshan city

Pls input.

..